US equities
|
MU
$1,035.84
▼-4.79%
NVDA
$230.48
▼-2.94%
SNDK
$1,609.46
▼-4.90%
AMD
$620.68
▼-3.90%
INTC
$107.08
▼-5.34%
AAPL
$340.42
▲+1.11%
SPCX
$160.57
▼-4.19%
META
$720.89
▼-0.06%
MU
$1,035.84
▼-4.79%
NVDA
$230.48
▼-2.94%
SNDK
$1,609.46
▼-4.90%
AMD
$620.68
▼-3.90%
INTC
$107.08
▼-5.34%
AAPL
$340.42
▲+1.11%
SPCX
$160.57
▼-4.19%
META
$720.89
▼-0.06%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tilray Brands Inc
(TSX:
TLRY
)
5.100
-0.220 (-4.14%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tilray Brands Inc
< Previous
1
2
...
14
15
16
17
18
19
20
21
Next >
Tilray, Inc. Reports 2021 Fiscal Year and Fourth Quarter Results
July 28, 2021
From
Tilray, Inc.
Via
Business Wire
CIBC Continues To Downgrade The Canadian Cannabis Sector
↗
July 27, 2021
One day after CIBC slashed its price target on Tilray, Inc. (TSX: TLRY) (Nasdaq: TLRY), the broker-dealer lowered its price target on Canopy Growth Corporation (TSX: WEED) (Nasdaq: CGC) to C$30 from...
Via
Talk Markets
Topics
Cannabis
CBD Product Sales Could Reach Nearly $17 Billion Dollars In The U.S. Alone By 2025
July 27, 2021
Via
FinancialNewsMedia
Topics
Cannabis
Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending That Tilray Shareholders Vote “FOR” All Proposals at Tilray’s Upcoming Special Meeting
July 21, 2021
From
Tilray, Inc.
Via
Business Wire
Tilray to Announce Fourth Quarter and Fiscal 2021 Financial Results on July 28, 2021
July 15, 2021
From
Tilray, Inc.
Via
Business Wire
CBD-Infused Beverages Market Is Expected to Exceed $14 Billion by End of 2026
July 13, 2021
Via
FinancialNewsMedia
Topics
Cannabis
Derivatives
Leading Independent Proxy Advisory Firm ISS Recommends Tilray Shareholders Vote “FOR” All Proposals at Tilray’s Upcoming Special Meeting
July 12, 2021
From
Tilray, Inc.
Via
Business Wire
Tilray’s Aphria RX GmbH Subsidiary Completes First Successful Harvest and Delivery of Medical Cannabis Grown in Germany
July 07, 2021
From
Tilray, Inc.
Via
Business Wire
Tilray Introduces Its First Cross-brand Product Collaboration and Launches Canadian Craft Cannabis Brand, Broken Coast, in the U.S.
June 30, 2021
From
Tilray, Inc.
Via
Business Wire
Tilray Asks Stockholders to Support Key Initiatives to Drive Strategic Growth and Strengthen Stockholder Rights
June 29, 2021
From
Tilray, Inc.
Via
Business Wire
Advancing Medical R&D for Cannabinoid Medicinal Uses Identifying Growing Number of Health Benefits
June 10, 2021
Via
FinancialNewsMedia
Topics
Cannabis
Tilray Announces Launch of New Medical Cannabis Brand, Symbios
June 08, 2021
From
Tilray, Inc.
Via
Business Wire
Global Cannabidiol (CBD) Market Size Expected to Reach $55 Billion In 2028
June 02, 2021
Via
FinancialNewsMedia
Topics
Cannabis
Tilray to Webcast Fireside Chats From Two Investor Conferences in June
May 25, 2021
From
Tilray, Inc.
Via
Business Wire
Tilray to Participate in BMO Capital Markets Investor Conference
May 13, 2021
From
Tilray, Inc.
Via
Business Wire
Cannabis Stock Movers: Top Advancers and Decliners on Wednesday 5/5/21
May 05, 2021
Via
FinancialNewsMedia
Topics
Cannabis
Tilray Commences Trading on the Toronto Stock Exchange Under Symbol “TLRY”
May 05, 2021
From
Tilray, Inc.
Via
Business Wire
< Previous
1
2
...
14
15
16
17
18
19
20
21
Next >
